Regis Healthcare (REG) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
18 Nov, 2025Opening remarks and agenda
Chair welcomed attendees, acknowledged traditional custodians, and introduced board members, executive team, and auditor.
Quorum confirmed, meeting formally opened, and voting procedures for both in-person and online participants explained.
Agenda included Chair and CEO addresses, formal business, Q&A, and closing.
Financial performance review
FY 2025 revenue reached AUD 1,161.3 million, up 14.5%, and underlying EBITDA was AUD 125.8 million, up 17.4%.
Underlying NPAT was AUD 53.4 million, up 37.3%.
Operating cash flows totaled AUD 306.1 million; net cash position improved to AUD 192.5 million.
Mature homes average occupancy increased to 95.6% in FY 2025; Q1 FY 2026 occupancy was 95.8%.
FY 2026 underlying EBITDA guidance remains AUD 130–135 million.
Board and executive committee updates
Ian Roberts and Sally Freeman stood for re-election, highlighting their experience and commitment; both supported by the board and re-elected with over 98% support.
Board comprised of experienced directors, including the Chair, CEO, and several independent non-executive directors.
Latest events from Regis Healthcare
- Record revenue and EBITDA growth, high occupancy, and robust cash flow amid sector reforms.REG
H2 20249 Jun 2026 - Revenue, EBITDA, and NPAT rose sharply, fueled by acquisitions and high occupancy.REG
H2 20259 Jun 2026 - Revenue and profit soared on occupancy, funding, and acquisitions; growth outlook remains strong.REG
H1 20259 Jun 2026 - Revenue up 18.4% and underlying EBITDA up 4%, with acquisitions fueling growth.REG
H1 20269 Jun 2026 - Strong financial growth, strategic expansion, and high shareholder approval highlighted the AGM.REG
AGM 202412 Jan 2026